. Author manuscript; available in PMC: 2011 Aug 1.

Published in final edited form as: Cancer Res. 2010 Jul 20;70(15):6303–6312. doi: 10.1158/0008-5472.CAN-10-1022

Table 1. MRI T₂ values after treatment of U87ΔEGFRvIII cells with free IONPs or EGFRvIIIAb-IONPs.

A., Cells were treated with free IONPs for 1 h; B. and C., A reduction in T₂ values (MRI contrast enhancement) was found after glioblastoma cells were treated for 1 and 2 h with EGFRvIIIAb-IONPs (shown in red).

	Sample	T₂ (cal.) s⁻¹
A	U87ΔEGFRvIII cells + IONPs 2h	0.053
B	U87ΔEGFRvIII cells + EGFRvIII Ab-IONPs 1h	0.037
C	U87ΔEGFRvIII cells + EGFRvIIIAb-IONPs 2h	0.026

Table 1. MRI T2 values after treatment of U87ΔEGFRvIII cells with free IONPs or EGFRvIIIAb-IONPs.

Table 1. MRI T₂ values after treatment of U87ΔEGFRvIII cells with free IONPs or EGFRvIIIAb-IONPs.